These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 10460985)
21. Drug therapy in the elderly. Turnheim K Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289 [TBL] [Abstract][Full Text] [Related]
22. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Corsonello A; Pedone C; Incalzi RA Curr Med Chem; 2010; 17(6):571-84. PubMed ID: 20015034 [TBL] [Abstract][Full Text] [Related]
23. [Changes in pharmacokinetics in elderly patients]. Nadai M; Katoh M Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202 [TBL] [Abstract][Full Text] [Related]
24. Drug dosage in the elderly. Is it rational? Turnheim K Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164 [TBL] [Abstract][Full Text] [Related]
25. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Aymanns C; Keller F; Maus S; Hartmann B; Czock D Clin J Am Soc Nephrol; 2010 Feb; 5(2):314-27. PubMed ID: 20056753 [TBL] [Abstract][Full Text] [Related]
26. [The kidneys and old age]. Fliser D Dtsch Med Wochenschr; 2008 Sep; 133(37):1835-8. PubMed ID: 18770483 [TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetic changes and drug therapy in an older population. Lamy PP J Am Geriatr Soc; 1982 Nov; 30(11 Suppl):S11-9. PubMed ID: 6752251 [TBL] [Abstract][Full Text] [Related]
28. [Age-related changes in morphological studies in rat and human kidney]. Takeda T; Imada A; Horiuchi A; Kimura M; Maekura S; Hashimoto S Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):555-62. PubMed ID: 9014474 [TBL] [Abstract][Full Text] [Related]
29. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705 [TBL] [Abstract][Full Text] [Related]
31. Acute kidney injury in the elderly: problems and prospects. Himmelfarb J Semin Nephrol; 2009 Nov; 29(6):658-64. PubMed ID: 20006798 [TBL] [Abstract][Full Text] [Related]
32. Contribution of the human kidney to the metabolic clearance of drugs. Vree TB; Hekster YA; Anderson PG Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449 [TBL] [Abstract][Full Text] [Related]
33. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity. Matzke GR; Frye RF Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of cardiovascular drugs in the elderly]. Imbs JL; Welsch M; Lates S Bull Acad Natl Med; 2006; 190(4-5):843-53; discussion 853, 873-6. PubMed ID: 17195611 [TBL] [Abstract][Full Text] [Related]
35. Some sodium, potassium and water changes in the elderly and their treatment. Andreucci VE; Russo D; Cianciaruso B; Andreucci M Nephrol Dial Transplant; 1996; 11 Suppl 9():9-17. PubMed ID: 9050029 [TBL] [Abstract][Full Text] [Related]
36. Aging and the kidney: clinical implications. Epstein M Am Fam Physician; 1985 Apr; 31(4):123-37. PubMed ID: 3885698 [TBL] [Abstract][Full Text] [Related]
37. Renal function and functional reserve in healthy elderly individuals. Esposito C; Plati A; Mazzullo T; Fasoli G; De Mauri A; Grosjean F; Mangione F; Castoldi F; Serpieri N; Cornacchia F; Dal Canton A J Nephrol; 2007; 20(5):617-25. PubMed ID: 17918149 [TBL] [Abstract][Full Text] [Related]